Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of extreme patient-reported outcome in early spondyloarthritis and its impact on the effect of TNF-α blockers treatment.

Clinical and experimental rheumatology - 1 Jan 2000

Meghnathi Bhowmik, Claudepierre Pascal, Dougados Maxime, Moltó Anna

Abstract excerpt

OBJECTIVES: To describe the prevalence of extreme patient-reported outcomes (PRO) in an early axial spondyloarthritis setting, to compare the phenotype of patients with/without extreme PRO and to evaluate the impact of extreme PRO on the effectiveness of TNF-α blockers (TNFb). METHODS: This analysis was performed in the DESIR cohort. Extreme PRO were measured at baseline and were defined as a score ≥8 on at least...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antirheumatic Agents
Share to Biological Products

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Patient Reported Outcome Measures

Share to Risk Factors

Share to Spondylarthritis

Share to Time Factors

Share to Treatment Outcome

Share to Tumor Necrosis Factor-alpha

Source

Identifiers

PMID: 30183594

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of extreme patient-reported outcome in early spondyloarthritis and its impact on the effect of TNF-α blockers treatment.PMID 30183594Read ↗

Identifying Clinical Features, Frailty and Treatment Responses of Late-onset Axial SpondiloarthritisSemantic proximity Read ↗

Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis: is the reason to switch relevant?Semantic proximity Read ↗

The occurrence and characteristics of severe pain in patients with axial spondyloarthritisSemantic proximity Read ↗

Clinical and imaging outcomes of different phenotypes of axial spondyloarthritis: 5-year analysis of the DESIR cohort.Semantic proximity Read ↗

Identifying flare prone Spondyloarthritis – insights from a prospective cohortSemantic proximity Read ↗

Concomitant Sjögren’s disease as a biomarker for treatment effectiveness in rheumatoid arthritis - results from the Swiss Clinical Quality Management cohortSemantic proximity Read ↗

Influence of initial axial involvement on the phenotypic evolution of axial spondyloarthritis: 10-year data from the DESIR cohort.Semantic proximity Read ↗

Regional differences in clinical phenotype of axial spondyloarthritis: results from the International Map of Axial Spondyloarthritis (IMAS).Semantic proximity Read ↗

Comparison of the ASAS Health Index in patients classified as radiographic axial spondyloarthritis (axSpA) or non-radiographic axSpA in the ASAS Health Index international validation study.Semantic proximity Read ↗

Adult-onset Still’s disease biological treatment strategy may depend on the phenotypic dichotomySemantic proximity Read ↗

Self-perceived general health at start of TNFi therapy predicts therapeutic response in patients with rheumatoid arthritis: analysis from the ATTRA registrySemantic proximity Read ↗

Biologic retention rate and efficacy in patients with cluster-based phenotypes of ankylosing spondylitis: data from a Korean national biologics registry.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.